- Projects & figures
- News & Events
- Managing your project
- About ERC
Two volunteers are the first above-knee amputees in the world to feel their prosthetic foot and knee in real time. Their bionic prosthesis, developed by a European team of researchers, has sensors that connect to residual nerves in the thigh. The resulting neurofeedback reduces physical and mental strain for prosthesis users as well as their phantom limb pain. They can also walk faster and with more confidence. Researchers, partly supported by ERC funds, recently reported on their achievement in Nature Medicine.
ERC grantee Juergen Brugger and his team have developed biodegradable microresonators that can be heated locally with a wireless system. Doctors could soon be using them in implants to control the release of painkillers within tissue.By Laure-Anne Pessina - Originally published on the EPFL website
How can we develop new materials that meet the extreme challenges of aerospace applications? Seizing the great potential of magnesium as a lightweight metal or making steels more resistant to failure and corrosion are two engineering challenges whose roots lie deep down at the atomic scale. Using models that bridge across scales from the atomic to the observable level, an ERC funded scientist investigates why materials behave and fail the way they do.
In only three years’ time, Dr Jan Tkač went from being the first ERC grantee in Slovakia to obtaining the “2015 Scientist of the Year” award. His research in the field of glyconomics could emerge as a turning point for the diagnosis of cell-related diseases.
In Bratislava, the team of Dr Ján Tkáč is developing the weapons to fight back in a cellular ‘cold war’ by using new early-detection technologies – helped by the first ERC grant awarded in Slovakia. Glycans are sugar molecules that carry the information human cells need to stay healthy and fight infections. Information rich, and with sophisticated storage and coding commands, they are a vital early-warning system for triggering an organism’s natural defensive systems at the first sign of attack. So it is not surprising that infectious pathogens such as bacteria and viruses, and cell-related diseases such as cancers, have developed subterfuges to bypass this first line of defence. For example, HIV viruses do this by cracking the glycan’s molecular code, and stealing its identity – allowing the pathogen to go unrecognised by cells until the infection is well advanced.